tradingkey.logo
搜尋

Inhibrx Biosciences Inc

INBX
添加自選
82.050USD
-2.680-3.16%
收盤 07-31 16:00美東報價延遲15分鐘
1.20B總市值
虧損本益比TTM

INBX 財務數據

透過專為投資者打造的一站式數據看板,全面查看 Inhibrx Biosciences Inc 的財務狀況。平台將複雜的財務報表整理為可自定義的視圖,助您更輕鬆地進行財務分析。您可以查看最新年度財務報告,也可以通過利潤表、資產負債表和現金流量表,按季度分析公司表現。借助實時財務指標,持續追蹤公司的經營狀況和市場表現更加便捷。

Inhibrx Biosciences Inc財報日曆

最新發布
5月 14, 2026
每股收益 / 預測值
-2.15/-1.79
營業收入 / 預測值
--/0.00
報告期
FY2025 財報
營業收入(YoY)
1.30M
550.00%
每股收益(YoY)
-9.04
-107.93%
分析師評級
BUY
2026/08/02
單季報
單季報+年報
單季報
年報
YOY
隱藏空白列
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
財務指標
每股收益
23.37%-2.15
31.67%-2.11
19.68%-2.28
-101.46%-1.85
-94.07%-2.80
-78.82%-3.09
-158.18%-2.84
11888.42%127.10
-28.53%-1.44
-83.08%-1.73
---1.10
---1.08
---1.12
---0.94
----
----
----
----
----
----
營業收入
----
-100.00%0.00
--0.00
1200.00%1.30M
----
-93.88%100.00K
-100.00%0.00
233.33%100.00K
-100.00%0.00
496.35%1.63M
-57.19%119.00K
-95.78%30.00K
-98.17%17.00K
-90.41%274.00K
-89.02%278.00K
-25.47%711.00K
4.50%929.00K
2.88%2.86M
-57.09%2.53M
-71.43%954.00K
淨利潤
22.79%-33.44M
31.40%-32.83M
19.62%-35.26M
-101.54%-28.65M
44.97%-43.31M
48.86%-47.87M
15.30%-43.86M
4048.85%1.86B
-60.91%-78.71M
-128.78%-93.60M
-46.61%-51.79M
-24.70%-47.05M
-56.51%-48.92M
-93.10%-40.91M
-71.65%-35.33M
-82.19%-37.73M
-62.03%-31.25M
-20.06%-21.19M
-0.40%-20.58M
-15.80%-20.71M
利潤率
----
----
----
-100.12%-2204.15%
----
-735.56%-47865.00%
----
1284.65%1858011.00%
----
61.64%-5728.52%
---43520.17%
---156840.00%
---287741.18%
---14932.48%
----
----
----
----
----
----
毛利率
----
----
----
0.00%100.00%
----
0.00%100.00%
----
0.00%100.00%
----
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
資產負債率
133.96%95.12%
--68.65%
--56.30%
--46.80%
-43.65%40.66%
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
-9.94%72.15%
-3.24%67.22%
--55.19%
--95.92%
--80.12%
--69.47%
----
----
----
----
----
----
營業收入
----
-100.00%0.00
--0.00
1200.00%1.30M
----
-93.88%100.00K
-100.00%0.00
233.33%100.00K
-100.00%0.00
496.35%1.63M
-57.19%119.00K
-95.78%30.00K
-98.17%17.00K
-90.41%274.00K
-89.02%278.00K
-25.47%711.00K
4.50%929.00K
2.88%2.86M
-57.09%2.53M
-71.43%954.00K
營業利潤
27.91%-30.93M
38.06%-30.92M
27.75%-33.81M
82.98%-27.39M
41.89%-42.90M
43.45%-49.93M
-2.12%-46.80M
-289.22%-160.90M
-68.68%-73.83M
-148.70%-88.29M
-52.74%-45.83M
-19.49%-41.34M
-50.83%-43.77M
-82.95%-35.50M
-59.58%-30.00M
-74.72%-34.60M
-56.36%-29.02M
-13.43%-19.40M
-20.84%-18.80M
-15.34%-19.80M
淨利潤
22.79%-33.44M
31.40%-32.83M
19.62%-35.26M
-101.54%-28.65M
44.97%-43.31M
48.86%-47.87M
15.30%-43.86M
4048.85%1.86B
-60.91%-78.71M
-128.78%-93.60M
-46.61%-51.79M
-24.70%-47.05M
-56.51%-48.92M
-93.10%-40.91M
-71.65%-35.33M
-82.19%-37.73M
-62.03%-31.25M
-20.06%-21.19M
-0.40%-20.58M
-15.80%-20.71M
流動資產
-23.30%171.34M
-17.19%132.83M
-22.19%161.42M
-19.87%193.96M
-18.63%223.39M
-45.69%160.40M
-42.90%207.45M
19.05%242.06M
12.62%274.54M
5.30%295.36M
136.28%363.30M
11.95%203.32M
62.08%243.78M
101.63%280.49M
29.17%153.75M
38.35%181.62M
32.63%150.40M
5.25%139.11M
-9.72%119.03M
1392.15%131.28M
流動負債總額
-39.25%26.51M
-17.02%33.80M
-18.40%35.98M
-0.29%38.94M
-39.28%43.64M
-27.67%40.73M
23.27%44.09M
24.65%39.05M
120.19%71.87M
104.21%56.31M
40.69%35.77M
29.45%31.33M
62.35%32.64M
22.81%27.58M
1.10%25.43M
11.67%24.20M
-27.81%20.11M
-28.49%22.45M
-27.60%25.15M
-27.21%21.67M
總資產
-24.18%183.97M
-18.97%146.48M
-20.26%177.47M
-17.92%212.12M
-15.92%242.64M
-41.29%180.77M
-40.29%222.56M
21.23%258.42M
13.74%288.58M
5.85%307.89M
126.10%372.73M
10.33%213.17M
57.41%253.72M
93.34%290.88M
27.62%164.85M
36.17%193.21M
29.46%161.18M
4.67%150.45M
-10.01%129.18M
566.10%141.89M
總負債
38.33%205.00M
193.51%138.49M
218.95%140.64M
267.61%143.56M
-46.50%148.20M
-82.15%47.18M
-81.86%44.09M
-83.59%39.05M
16.11%277.01M
13.56%264.39M
21.63%243.14M
20.11%237.98M
78.27%238.58M
137.41%232.82M
97.97%199.90M
103.07%198.13M
109.41%133.83M
43.65%98.07M
94.84%100.98M
10.45%97.57M
總權益
-122.27%-21.04M
-94.02%7.99M
-79.36%36.83M
-68.75%68.56M
716.42%94.44M
207.07%133.58M
37.71%178.47M
984.11%219.37M
-23.56%11.57M
-25.07%43.50M
469.74%129.59M
-404.10%-24.81M
-44.67%15.13M
10.83%58.06M
-224.29%-35.05M
-111.11%-4.92M
-54.86%27.35M
-30.59%52.38M
-69.26%28.20M
166.11%44.32M
經營淨額
-5.94%-38.03M
31.10%-30.12M
-11.70%-33.82M
47.78%-29.95M
43.07%-35.90M
23.06%-43.72M
44.18%-30.28M
-35.60%-57.36M
-57.85%-63.05M
-85.69%-56.82M
-75.90%-54.24M
-57.12%-42.30M
-48.26%-39.94M
-35.28%-30.60M
-125.51%-30.84M
-20.29%-26.92M
-24.45%-26.94M
-46.99%-22.62M
1.49%-13.68M
-97.90%-22.38M
投資淨額
100.00%0.00
100.00%0.00
97.17%-7.00K
100.00%0.00
98.12%-21.00K
99.54%-16.00K
69.54%-247.00K
-283.28%-1.22M
-4765.22%-1.12M
-1189.14%-3.44M
-4155.00%-811.00K
1.55%-317.00K
80.34%-23.00K
0.00%-267.00K
111.83%20.00K
10.31%-322.00K
-735.71%-117.00K
56.37%-267.00K
43.48%-169.00K
0.83%-359.00K
融資淨額
-24.42%75.46M
--1.25M
--352.00K
-100.00%0.00
157.80%99.84M
-100.00%0.00
-100.00%0.00
3758.31%32.95M
10778.65%38.73M
-99.46%860.00K
39404.15%199.89M
-98.58%854.00K
-99.09%356.00K
282.46%158.66M
-38.29%506.00K
48.63%60.16M
3870.04%39.22M
144.08%41.48M
-99.40%820.00K
139.86%40.48M

常見問題

Inhibrx Biosciences Inc的總收入是多少?

根據Inhibrx Biosciences Inc的FY2025財報,總收入達到1.30M(同比變化200.00K)。

Inhibrx Biosciences Inc的流動資產是多少?

根據Inhibrx Biosciences Inc的FY2025財報,流動資產為132.83M(同比變化-17.19)。

Inhibrx Biosciences Inc的總資產是多少?

根據Inhibrx Biosciences Inc的FY2025財報,Inhibrx Biosciences Inc的總資產為146.48M(同比變化-18.97)。

Inhibrx Biosciences Inc的總負債是多少?

根據Inhibrx Biosciences Inc的FY2025財報,Inhibrx Biosciences Inc的總責任為138.49M(同比變化193.51)。

Inhibrx Biosciences Inc的總權益是多少?

根據Inhibrx Biosciences Inc的FY2025財報,Inhibrx Biosciences Inc的總權益為7.99M(同比變化-94.02)。

Inhibrx Biosciences Inc的淨營業收入是多少?

根據Inhibrx Biosciences Inc的FY2025財報,Inhibrx Biosciences Inc的淨營業收入為-135.03M(同比變化59.26)。

Inhibrx Biosciences Inc的淨投資是多少?

根據Inhibrx Biosciences Inc的FY2025財報,Inhibrx Biosciences Inc的淨投資為-28.00K(同比變化98.92)。

Inhibrx Biosciences Inc的淨融資是多少?

根據Inhibrx Biosciences Inc的FY2025財報,Inhibrx Biosciences Inc的淨融資為101.45M(同比變化41.53)。

Inhibrx Biosciences Inc的每股收益(EPS)是多少?

根據Inhibrx Biosciences Inc的FY2025財報,每股收益(EPS)為-9.04(同比變化-107.93)。

Inhibrx Biosciences Inc的淨利潤是多少?

根據Inhibrx Biosciences Inc的FY2025財報,淨利潤為-140.06M(同比變化-108.30)。

Inhibrx Biosciences Inc的淨利潤率是多少?

根據Inhibrx Biosciences Inc的FY2025財報,淨利潤率為-10773.46(同比變化-101.28)。

Inhibrx Biosciences Inc的股東權益回報率(ROE)是多少?

根據Inhibrx Biosciences Inc的FY2025財報,股東權益回報率(ROE)為-197.85(同比變化-110.38)。

Inhibrx Biosciences Inc的資產回報率(ROA)是多少?

根據Inhibrx Biosciences Inc的FY2025財報,資產回報率(ROA)為-85.60(同比變化-112.39)。

Inhibrx Biosciences Inc的營業利潤是多少?

根據Inhibrx Biosciences Inc的FY2025財報,營業利潤為-135.03M(同比變化59.26)。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有